BRISTOL-MYERS SQUIBB COMPANY Amortization
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Amortization of $203.00 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2012-07-25
- BRISTOL-MYERS SQUIBB COMPANY amortization for the quarter ending 2012-06-30 was $102.00M, a 7.37% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization for the quarter ending 2012-03-31 was $101.00M, a 38.36% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization for the quarter ending 2011-12-31 was $92.00M, a 26.03% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization for the quarter ending 2011-09-30 was $93.00M, a 40.91% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization for fiscal 2011 was $353.00M, a 30.26% increase from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY amortization for fiscal 2010 was $271.00M, a 13.87% increase from fiscal 2009.
- BRISTOL-MYERS SQUIBB COMPANY amortization for fiscal 2009 was $238.00M, a 6.30% decline from fiscal 2008.
- BRISTOL-MYERS SQUIBB COMPANY amortization for fiscal 2008 was $254.00M, a 27.43% decline from fiscal 2007.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 6 month as first filed | Amortization 9 month | Amortization 9 month as first filed | Amortization 12 month |
|---|---|---|---|---|---|---|
| 2012-06-30 | $102.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $203.00M 10-Q · filed 2012-07-25 | $295.00M derived: sum of 3 quarters · filed 2012-07-25 | $388.00M derived: sum of 4 quarters · filed 2012-07-25 | ||
| 2012-03-31 | $101.00M 10-Q · filed 2012-04-26 | $193.00M derived: sum of 2 quarters · filed 2012-04-26 | $286.00M derived: sum of 3 quarters · filed 2012-04-26 | $381.00M derived: sum of 4 quarters · filed 2012-07-25 | ||
| 2011-12-31 | $92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $185.00M derived: sum of 2 quarters · filed 2012-02-17 | $280.00M derived: sum of 3 quarters · filed 2012-07-25 | $353.00M 10-K · filed 2012-02-17 | ||
| 2011-09-30 | $93.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $188.00M derived: sum of 2 quarters · filed 2012-07-25 | $261.00M 10-Q · filed 2011-10-27 | $334.00M derived: sum of 4 quarters · filed 2012-07-25 | ||
| 2011-06-30 | $95.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $168.00M 10-Q · filed 2012-07-25 | $241.00M derived: sum of 3 quarters · filed 2012-07-25 | $307.00M derived: sum of 4 quarters · filed 2012-07-25 | ||
| 2011-03-31 | $73.00M 10-Q · filed 2012-04-26 | $146.00M derived: sum of 2 quarters · filed 2012-04-26 | $212.00M derived: sum of 3 quarters · filed 2012-04-26 | $279.00M derived: sum of 4 quarters · filed 2012-04-26 | ||
| 2010-12-31 | $73.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $139.00M derived: sum of 2 quarters · filed 2012-02-17 | $206.00M derived: sum of 3 quarters · filed 2012-02-17 | $271.00M 10-K · filed 2012-02-17 | ||
| 2010-09-30 | $66.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | $133.00M derived: sum of 2 quarters · filed 2011-10-27 | $198.00M 10-Q · filed 2011-10-27 | $259.00M derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-06-30 | $67.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $132.00M 10-Q · filed 2011-07-28 | $193.00M derived: sum of 3 quarters · filed 2012-02-17 | $257.00M derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-03-31 | $65.00M 10-Q · filed 2011-04-28 | $126.00M derived: sum of 2 quarters · filed 2012-02-17 | $190.00M derived: sum of 3 quarters · filed 2012-02-17 | $246.00M derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2009-12-31 | $61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $125.00M derived: sum of 2 quarters · filed 2012-02-17 | $181.00M derived: sum of 3 quarters · filed 2012-02-17 | $238.00M 10-K · filed 2012-02-17 | ||
| 2009-09-30 | $64.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $120.00M derived: sum of 2 quarters · filed 2010-10-26 | $177.00M 10-Q · filed 2010-10-26 | $160.00M 10-Q · filed 2009-10-22 | $244.00M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-22 | $113.00M 10-Q · filed 2010-07-22 | $101.00M 10-Q · filed 2009-07-23 | $180.00M derived: sum of 3 quarters · filed 2011-02-18 | $241.00M derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $57.00M 10-Q · filed 2010-04-29 | $124.00M derived: sum of 2 quarters · filed 2011-02-18 | $185.00M derived: sum of 3 quarters · filed 2011-02-18 | |||
| 2008-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $128.00M derived: sum of 2 quarters · filed 2011-02-18 | $254.00M 10-K · filed 2011-02-18 | |||
| 2008-09-30 | $61.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-22 | $187.00M 10-Q · filed 2009-10-22 | ||||
| 2008-06-30 | $126.00M 10-Q · filed 2009-07-23 | |||||
| 2007-12-31 | $350.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |